Skip to main content
Erschienen in: Journal of Clinical Immunology 6/2011

01.12.2011

Transgenic Mice that Overexpress Human IL-15 in Enterocytes Recapitulate Both B and T Cell-Mediated Pathologic Manifestations of Celiac Disease

verfasst von: Seiji Yokoyama, Kazuko Takada, Masatomo Hirasawa, Liyanage P. Perera, Takachika Hiroi

Erschienen in: Journal of Clinical Immunology | Ausgabe 6/2011

Einloggen, um Zugang zu erhalten

Abstract

Celiac disease (CD) is a chronic immune-mediated intestinal inflammatory disorder afflicting genetically susceptible individuals triggered by the consumption of dietary cereals with high gluten content. As with many other organ-specific autoimmune diseases, the dominant tissue-destructive inflammation in CD is T cell-mediated. The proinflammatory cytokine IL-15 that is overexpressed in the intestinal epithelium of CD patients has emerged as a pivotal element that orchestrates intestinal inflammation and T cell-mediated autoimmune tissue destruction. Although no animal model exists that recapitulates the full spectrum of CD pathophysiology, we have previously reported that transgenic mice that overexpress human IL-15 in enterocytes (T3b-hlL-15 Tg) display many of the T cell-mediated pathologic features seen in CD. Extending these observations, we now report that T3b-hlL-15 Tg mice in addition to recapitulating T cell-mediated effects also display autoantibodies including those against tissue transglutaminase 2 and extensive lamina propria plasmacytosis, all of which are characteristic of CD, thereby reflecting the possibility that locally expressed IL-15 drives both T and B cell pathologic effects seen in CD. More importantly, these findings support the validity and utility of T3b-hlL-15 Tg mice as a reasonable model to investigate not only tissue-destructive pathologic processes in CD, but also to explore novel therapeutic modalities for the treatment of this disease.
Literatur
1.
Zurück zum Zitat Kagnoff MF. Celiac disease: pathogenesis of a model immunogenetic disease. J Clin Invest. 2007;117(1):41–9.PubMedCrossRef Kagnoff MF. Celiac disease: pathogenesis of a model immunogenetic disease. J Clin Invest. 2007;117(1):41–9.PubMedCrossRef
2.
Zurück zum Zitat Abadie V, Sollid LM, Barreiro LB, Jabri B. Integration of genetic and immunological insights into a model of celiac disease pathogenesis. Annu Rev Immunol. 2010;29:493–525.CrossRef Abadie V, Sollid LM, Barreiro LB, Jabri B. Integration of genetic and immunological insights into a model of celiac disease pathogenesis. Annu Rev Immunol. 2010;29:493–525.CrossRef
3.
Zurück zum Zitat Marsh MN. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity (‘celiac sprue’). Gastroenterology. 1992;102(1):330–54.PubMed Marsh MN. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity (‘celiac sprue’). Gastroenterology. 1992;102(1):330–54.PubMed
4.
Zurück zum Zitat Hue S, Mention JJ, Monteiro RC, Zhang S, Cellier C, Schmitz J, et al. A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease. Immunity. 2004;21(3):367–77.PubMedCrossRef Hue S, Mention JJ, Monteiro RC, Zhang S, Cellier C, Schmitz J, et al. A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease. Immunity. 2004;21(3):367–77.PubMedCrossRef
5.
Zurück zum Zitat Scott BB, Goodall A, Stephenson P, Jenkins D. Small intestinal plasma cells in coeliac disease. Gut. 1984;25(1):41–6.PubMedCrossRef Scott BB, Goodall A, Stephenson P, Jenkins D. Small intestinal plasma cells in coeliac disease. Gut. 1984;25(1):41–6.PubMedCrossRef
6.
Zurück zum Zitat Malamut G, El Machhour R, Montcuquet N, Martin-Lanneree S, Dusanter-Fourt I, Verkarre V, et al. IL-15 triggers an antiapoptotic pathway in human intraepithelial lymphocytes that is a potential new target in celiac disease-associated inflammation and lymphomagenesis. J Clin Invest. 2010;120(6):2131–43.PubMedCrossRef Malamut G, El Machhour R, Montcuquet N, Martin-Lanneree S, Dusanter-Fourt I, Verkarre V, et al. IL-15 triggers an antiapoptotic pathway in human intraepithelial lymphocytes that is a potential new target in celiac disease-associated inflammation and lymphomagenesis. J Clin Invest. 2010;120(6):2131–43.PubMedCrossRef
7.
Zurück zum Zitat Meresse B, Chen Z, Ciszewski C, Tretiakova M, Bhagat G, Krausz TN, et al. Coordinated induction by IL.15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity. 2004;21(3):357–66.PubMedCrossRef Meresse B, Chen Z, Ciszewski C, Tretiakova M, Bhagat G, Krausz TN, et al. Coordinated induction by IL.15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity. 2004;21(3):357–66.PubMedCrossRef
8.
Zurück zum Zitat DePaolo RW, Abadie V, Tang F, Fehlner-Peach H, Hall JA, Wang W, et al. Co-adjuvant effects of retinoic acid and IL-15 induce inflammatory immunity to dietary antigens. Nature. 2011;471(7337):220–4.PubMedCrossRef DePaolo RW, Abadie V, Tang F, Fehlner-Peach H, Hall JA, Wang W, et al. Co-adjuvant effects of retinoic acid and IL-15 induce inflammatory immunity to dietary antigens. Nature. 2011;471(7337):220–4.PubMedCrossRef
9.
Zurück zum Zitat Benahmed M, Meresse B, Arnulf B, Barbe U, Mention JJ, Verkarre V, et al. Inhibition of TGF-beta signaling by IL-15: a new role for IL-15 in the loss of immune homeostasis in celiac disease. Gastroenterology. 2007;132(3):994–1008.PubMedCrossRef Benahmed M, Meresse B, Arnulf B, Barbe U, Mention JJ, Verkarre V, et al. Inhibition of TGF-beta signaling by IL-15: a new role for IL-15 in the loss of immune homeostasis in celiac disease. Gastroenterology. 2007;132(3):994–1008.PubMedCrossRef
10.
Zurück zum Zitat Yokoyama S, Watanabe N, Sato N, Perera PY, Filkoski L, Tanaka T, et al. Antibody-mediated blockade of IL-15 reverses the autoimmune intestinal damage in transgenic mice that overexpress IL-15 in enterocytes. Proc Natl Acad Sci USA. 2009;106(37):15849–54.PubMedCrossRef Yokoyama S, Watanabe N, Sato N, Perera PY, Filkoski L, Tanaka T, et al. Antibody-mediated blockade of IL-15 reverses the autoimmune intestinal damage in transgenic mice that overexpress IL-15 in enterocytes. Proc Natl Acad Sci USA. 2009;106(37):15849–54.PubMedCrossRef
11.
Zurück zum Zitat Ohta N, Hiroi T, Kweon MN, Kinoshita N, Jang MH, Mashimo T, et al. IL-15-dependent activation-induced cell death-resistant Th1 type CD8 alpha beta+NK1.1+ T cells for the development of small intestinal inflammation. J Immunol. 2002;169(1):460–8.PubMed Ohta N, Hiroi T, Kweon MN, Kinoshita N, Jang MH, Mashimo T, et al. IL-15-dependent activation-induced cell death-resistant Th1 type CD8 alpha beta+NK1.1+ T cells for the development of small intestinal inflammation. J Immunol. 2002;169(1):460–8.PubMed
12.
Zurück zum Zitat Kweon MN, Yamamoto M, Kajiki M, Takahashi I, Kiyono H. Systemically derived large intestinal CD4(+) Th2 cells play a central role in STAT6-mediated allergic diarrhea. J Clin Invest. 2000;106(2):199–206.PubMedCrossRef Kweon MN, Yamamoto M, Kajiki M, Takahashi I, Kiyono H. Systemically derived large intestinal CD4(+) Th2 cells play a central role in STAT6-mediated allergic diarrhea. J Clin Invest. 2000;106(2):199–206.PubMedCrossRef
13.
Zurück zum Zitat de Kauwe AL, Chen Z, Anderson RP, Keech CL, Price JD, Wijburg O, et al. Resistance to celiac disease in humanized HLA-DR3-DQ2-transgenic mice expressing specific anti-gliadin CD4+ T cells. J Immunol. 2009;182(12):7440–50.PubMedCrossRef de Kauwe AL, Chen Z, Anderson RP, Keech CL, Price JD, Wijburg O, et al. Resistance to celiac disease in humanized HLA-DR3-DQ2-transgenic mice expressing specific anti-gliadin CD4+ T cells. J Immunol. 2009;182(12):7440–50.PubMedCrossRef
14.
Zurück zum Zitat Bobe P, Bonardelle D, Benihoud K, Opolon P, Chelbi-Alix MK. Arsenic trioxide: a promising novel therapeutic agent for lymphoproliferative and autoimmune syndromes in MRL/lpr mice. Blood. 2006;108(13):3967–75.PubMedCrossRef Bobe P, Bonardelle D, Benihoud K, Opolon P, Chelbi-Alix MK. Arsenic trioxide: a promising novel therapeutic agent for lymphoproliferative and autoimmune syndromes in MRL/lpr mice. Blood. 2006;108(13):3967–75.PubMedCrossRef
15.
Zurück zum Zitat Jang MH, Sougawa N, Tanaka T, Hirata T, Hiroi T, Tohya K, et al. CCR7 is critically important for migration of dendritic cells in intestinal lamina propria to mesenteric lymph nodes. J Immunol. 2006;176(2):803–10.PubMed Jang MH, Sougawa N, Tanaka T, Hirata T, Hiroi T, Tohya K, et al. CCR7 is critically important for migration of dendritic cells in intestinal lamina propria to mesenteric lymph nodes. J Immunol. 2006;176(2):803–10.PubMed
16.
Zurück zum Zitat Dieterich W, Ehnis T, Bauer M, Donner P, Volta U, Riecken EO, et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med. 1997;3(7):797–801.PubMedCrossRef Dieterich W, Ehnis T, Bauer M, Donner P, Volta U, Riecken EO, et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med. 1997;3(7):797–801.PubMedCrossRef
17.
Zurück zum Zitat Lerner A, Blank M, Lahat N, Shoenfeld Y. Increased prevalence of autoantibodies in celiac disease. Dig Dis Sci. 1998;43(4):723–6.PubMedCrossRef Lerner A, Blank M, Lahat N, Shoenfeld Y. Increased prevalence of autoantibodies in celiac disease. Dig Dis Sci. 1998;43(4):723–6.PubMedCrossRef
18.
Zurück zum Zitat Hällgren J, Knutson F, Lavö B, Hällgren R. Increased mucosal synthesis of rheumatoid factor (RF) in coeliac disease. Clin Exp Immunol. 1996;103(1):94–8.PubMedCrossRef Hällgren J, Knutson F, Lavö B, Hällgren R. Increased mucosal synthesis of rheumatoid factor (RF) in coeliac disease. Clin Exp Immunol. 1996;103(1):94–8.PubMedCrossRef
19.
Zurück zum Zitat Granito A, Muratori P, Cassani F, Pappas G, Muratori L, Agostinelli D, et al. Anti-actin IgA antibodies in severe coeliac disease. Clin Exp Immunol. 2004;137(2):386–92.PubMedCrossRef Granito A, Muratori P, Cassani F, Pappas G, Muratori L, Agostinelli D, et al. Anti-actin IgA antibodies in severe coeliac disease. Clin Exp Immunol. 2004;137(2):386–92.PubMedCrossRef
20.
Zurück zum Zitat Teesalu K, Uibo O, Kalkkinen N, Janmey P, Uibo R. Increased levels of IgA antibodies against desmin in children with coeliac disease. Int Arch Allergy Immunol. 2001;126(2):157–66.PubMedCrossRef Teesalu K, Uibo O, Kalkkinen N, Janmey P, Uibo R. Increased levels of IgA antibodies against desmin in children with coeliac disease. Int Arch Allergy Immunol. 2001;126(2):157–66.PubMedCrossRef
21.
Zurück zum Zitat Wood GM, Howdle PD, Trejdosiewicz LK, Losowsky MS. Jejunal plasma cells and in vitro immunoglobulin production in adult coeliac disease. Clin Exp Immunol. 1987;69(1):123–32.PubMed Wood GM, Howdle PD, Trejdosiewicz LK, Losowsky MS. Jejunal plasma cells and in vitro immunoglobulin production in adult coeliac disease. Clin Exp Immunol. 1987;69(1):123–32.PubMed
22.
Zurück zum Zitat Brandtzaeg P. The changing immunological paradigm in coeliac disease. Immunol Lett. 2006;105(2):127–39.PubMedCrossRef Brandtzaeg P. The changing immunological paradigm in coeliac disease. Immunol Lett. 2006;105(2):127–39.PubMedCrossRef
23.
Zurück zum Zitat Black KE, Murray JA, David CS. HLA-DQ determines the response to exogenous wheat proteins: a model of gluten sensitivity in transgenic knockout mice. J Immunol. 2002;169(10):5595–600.PubMed Black KE, Murray JA, David CS. HLA-DQ determines the response to exogenous wheat proteins: a model of gluten sensitivity in transgenic knockout mice. J Immunol. 2002;169(10):5595–600.PubMed
24.
Zurück zum Zitat Marietta E, Black K, Camilleri M, Krause P, Rogers 3rd RS, David C, et al. A new model for dermatitis herpetiformis that uses HLA-DQ8 transgenic NOD mice. J Clin Invest. 2004;114(8):1090–7.PubMed Marietta E, Black K, Camilleri M, Krause P, Rogers 3rd RS, David C, et al. A new model for dermatitis herpetiformis that uses HLA-DQ8 transgenic NOD mice. J Clin Invest. 2004;114(8):1090–7.PubMed
25.
Zurück zum Zitat Salmi TT, Collin P, Jarvinen O, Haimila K, Partanen J, Laurila K, et al. Immunoglobulin A autoantibodies against transglutaminase 2 in the small intestinal mucosa predict forthcoming coeliac disease. Aliment Pharmacol Ther. 2006;24(3):541–52.PubMedCrossRef Salmi TT, Collin P, Jarvinen O, Haimila K, Partanen J, Laurila K, et al. Immunoglobulin A autoantibodies against transglutaminase 2 in the small intestinal mucosa predict forthcoming coeliac disease. Aliment Pharmacol Ther. 2006;24(3):541–52.PubMedCrossRef
26.
Zurück zum Zitat Kitamura D, Roes J, Kühn R, Rajewsky K. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μ chain gene. Nature. 1991;350(6317):423–6.PubMedCrossRef Kitamura D, Roes J, Kühn R, Rajewsky K. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μ chain gene. Nature. 1991;350(6317):423–6.PubMedCrossRef
27.
Zurück zum Zitat Hiroi T, Yanagita M, Ohta N, Sakaue G, Kiyono H. IL-15 and IL-15 receptor selectively regulate differentiation of common mucosal immune system-independent B-1 cells for IgA responses. J Immunol. 2000;165(8):4329–37.PubMed Hiroi T, Yanagita M, Ohta N, Sakaue G, Kiyono H. IL-15 and IL-15 receptor selectively regulate differentiation of common mucosal immune system-independent B-1 cells for IgA responses. J Immunol. 2000;165(8):4329–37.PubMed
28.
Zurück zum Zitat Waldmann TA. The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design. Nat Rev Immunol. 2006;6(8):595–601.PubMedCrossRef Waldmann TA. The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design. Nat Rev Immunol. 2006;6(8):595–601.PubMedCrossRef
29.
Zurück zum Zitat Perera LP. Interleukin 15: its role in inflammation and immunity. Arch Immunol Ther Exp (Warsz). 2000;48(6):457–64. Perera LP. Interleukin 15: its role in inflammation and immunity. Arch Immunol Ther Exp (Warsz). 2000;48(6):457–64.
Metadaten
Titel
Transgenic Mice that Overexpress Human IL-15 in Enterocytes Recapitulate Both B and T Cell-Mediated Pathologic Manifestations of Celiac Disease
verfasst von
Seiji Yokoyama
Kazuko Takada
Masatomo Hirasawa
Liyanage P. Perera
Takachika Hiroi
Publikationsdatum
01.12.2011
Verlag
Springer US
Erschienen in
Journal of Clinical Immunology / Ausgabe 6/2011
Print ISSN: 0271-9142
Elektronische ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-011-9586-7

Weitere Artikel der Ausgabe 6/2011

Journal of Clinical Immunology 6/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.